Table 3.
Author | Number randomized | Interventions | Outcome measures | Results |
---|---|---|---|---|
Colgan et al40 | 80 | All had 2-layer compression Gp1: 400 mg tds pentoxifylline Gp2: placebo |
Healing at 24 weeks | Gp1: 60% healed Gp2: 29% healed |
Barbarino41 | 12 | All had 2-layer compression Gp1: 400 mg tds pentoxifylline Gp2: placebo |
Healing | Gp1: 66% healed Gp2: 17% healed |
Dale et al42 | 200 | All had compression Gp1:400 mg tds pentoxifylline Gp2: placebo |
Healing at 24 weeks | Gp1: 64% healed Gp2: 52% healed |
Falanga et al43 | 129 | All had compression Gp1: 800 mg tds pentoxifylline Gp2: 400 mg tds pentoxifylline Gp3: placebo |
Healing at 24 weeks | Gp1: 73% healed Gp2: 75% healed Gp3: 63% healed |
Belcaro et al44 | 172 | All had 2-layer compression Gp1: 400 mg tds pentoxifylline Gp2: placebo |
Healing and reduction in ulcer size | Gp1: 65% healed, 87% size reduction Gp2: 27% healed, 47% size reduction |
Nikolovska et al45 | 80 | All had hydrocolloid dressing One group had 400 mg tds pentoxifylline | Healing at 24 weeks | 58% healed in pentoxifylline group and 28% in no tablet group |
Abbreviations: Gp1, group 1; Gp2, group 2; Gp3, group 3.